Interventions for preventing relapse and recurrence after the first episode of a depressive disorder in young people
References
Additional references
Allen NB, Hetrick SE, Simmons JG, Hickie IB. Early intervention in depressive disorders in young people: the opportunity and the (lack of) evidence. Medical Journal of Australia 2007;187(7 suppl):s15‐s17.
Belsher G, Costello CG. Relapse after recovery from unipolar depression: a critical review. Psychological Bulletin 1988;104(1):84‐96.
Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Keller MB. Lost human capital from early‐onset chronic depression. American Journal Psychiatry 2000;157(6):940‐7.
Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE. Childhood and adolescent depression: A review of the past 10 years: Part 1. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(11):1427‐39.
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment a meta‐analysis of randomized controlled trials. Journal of the American Medical Association 2007;297(15):1683‐1696.
Clarke GN, Rohde P, Lewinsohn PM, Hops, H, Seeley JR. Cognitive‐behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child & Adolescent Psychiatry 1999;38(3):272‐9.
Clarke G, Debar L, Lynch F, Powell J, Gale J, O'Connor E, et al. A randomized effectiveness trial of brief cognitive‐behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child & Adolescent Psychiatry 2005;44:888‐98.
Costello JE, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression?. Journal of Child Psychology and Psychiatry 2006;47(12):1263–71.
Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM. The impact of treatment‐resistant depression on health care utilization and costs. Journal of Clinical Psychiatry 2002;63(11):963‐971.
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88.
Emslie GJ, Heiligenstein JH, Hoog SL, Wagner, KD, Findling RL, McCracken JT, Nilsson ME, Jacobson JG. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double‐blind, placebo‐controlled study. Journal of the American Academy of Child & Adolescent Psychiatry 2004;43(11):1397‐405.
Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361(9358):653‐61.
Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. British Medical Journal 2007;335(7611):142 Epub. [DOI: 10.1136/bmj.39224.494340.5.]
Harrington R, Fudge H, Rutter M, Pickles A, Hill J. Adult outcomes of childhood and adolescent depression. I. Psychiatric status. Archives of General Psychiatry 1990;47(5):465‐73.
Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD002317]
Hensley PL, Nadiga D, Uhlenhuth EH. Long‐term effectiveness of cognitive therapy in major depressive disorder. Depression & Anxiety 2004;20(1):1‐7.
Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD004851. DOI: 10.1002/14651858.CD004851pub2]
Hetrick SE, Parker AG, Purcell R, Hickie I, Yung AR, McGorry PD. Early identification and intervention in depressive disorders: toward a clinical staging model. Journal of Psychotherapy and Psychosomatics 2008;77(5):263‐270.
Higgins JPT, Green S, editors. Cochrane Handbook of Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. www.cochrane.org/resouces/handbook/hbook.htm (accessed 21 July 2008).
Keller MB, Ruwe FKL, Janssens CJJG, Sitsen JM Ad, Jokinen R, Janczewski J. Relapse prevention with gepirone ER in outpatients with major depression. Journal of Clinical Pharmacology 2005;25(1):79‐84.
Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. American Journal of Psychiatry 2000;157(8):1243‐1251.
Kennedy N, Abbott R, Paykel ES. Remission and recurrence of depression in the maintenance era: long‐term outcome in a Cambridge cohort. Psychological Medicine 2003;33:827‐838.
Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994‐1999. British Journal of Psychiatry 2004;185:372‐7.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters, EE. Lifetime prevalence and age‐of‐onset distributions of DSM‐IV disorders in the National Comorbidity Survey replication. Archives of General Psychiatry 2005;62:593‐602.
Kroll L Harrington R Jayson D, et al. Pilot study of continuation cognitive‐behavioral therapy for major depression in adolescent psychiatric patients. Journal of the American Academy of Child & Adolescent Psychiatry 1996;35(9):1156‐61.
Lewinsohn PM, Allen NB, Seeley JR, Gotlib IH. First onset versus recurrence of depression: Differential processes of psychosocial risk. Journal of Abnormal Psychology 1999;108:483‐489.
Ma SH, Teasdale JD. Mindfulness‐based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 2004;72(1):31‐40.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the Nationall Cancer Institute 1959;22:719‐48.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J et al (Treatment for Adolescents with Depression Team). Fluoxetine, cognitive‐behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association 2004;292(7):807‐20.
McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian & New Zealand Journal of Psychiatry 2006;40:616‐622.
Melvin GA, Tonge BJ, King NJ, Heyne D, Gordon MS, Klimkeit EA. comparison of cognitive‐behavioral therapy, sertraline, and their combination for adolescent depression. Journal of the American Academy of Child & Adolescent Psychiatry 2006;45:1151‐61.
Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry 1992;149(8):999‐1010.
Rapaport MH, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. Journal of Clinical Psychopharmacology 2004;65(1):44‐9.
Rutter M, Smith DJ. Psychosocial Disorders in Young People, Time Trends and Their Causes. Psychosocial Disorders in Young People, Time Trends and Their Causes. Chichester, England: John Wiley & Sons, 1995.
Simon JS, Aguiar LM, Kunz NR, Lei D. Extended‐release venlafaxine in relapse prevention for patients with major depressive disorder. Journal of Psychiatric Research 2004;38(3):249‐57.
Teasdale JD, Segal ZV, Willaims JMG, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness‐based cognitive therapy. Journal of Consulting and Clinical Psychology 2000;68(4):615‐623.
Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta‐analysis. Psychological Bulletin 2006;132:132‐149.
